Coya Therapeutics, Inc. (COYA) Tops Q2 EPS by 42c
Tweet
Share
E-mailGet Alerts COYA Hot Sheet
Join SI Premium – FREE
Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.28), $0.42 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $240 thousand.
For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- JPMorgan Reiterates Underweight Rating on Hapag-Lloyd AG (HLAG:GR) (HLAGF)
- BofA Securities Downgrades StubHub Holdings (STUB) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
